Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial.
Clémentine RoucherIsabel BrosiusMoustapha MbowBabacar Thiendella FayeAnnelies De HondtBart SmekensDiana ArangoChristophe BurmAchilleas TsoumanisLinda ParedisYven van HerrewegeIdzi PottersBadara CisseSouleymane MboupKatja PolmanEmmanuel BottieauPublished in: BMJ open (2021)
NCT03893097; pre-results.